News

Job loss may negatively impact your patient’s mental health. Read about how you can help.

Read about the new results from Sage’s clinical study of depression treatment, zuranolone.

The risk of “false positive” screening in primary care settings is reduced by a thorough clinical evaluation.

Terrorism is a crime from which the families of the victims may never recover. A recent study examines the grieving process in depth.

Bipolar disorder screening scales have modest sensitivity; thus, a negative result does not preclude a clinical evaluation.

This case illustrates the practical implications and effectiveness of the Minnesota Multiphasic Personality Inventory-2 in documenting patient recovery during treatment for delusional disorder.

There are epidemiological and clinical reasons why we should drop that term.

It is time for psychiatrists to tackle the toughest philosophical questions in their field.

A psychiatrist considers the role of race in American culture, psychiatry, and his own life.

Alkermes plc’s new drug, ALKS 3831, pending FDA approval, could be helpful in the treatment of patients with schizophrenia or bipolar I disorder.

The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.

Cannabis use during pregnancy is associated with a host of negative outcomes.

At the heart of reopening is protecting both population health and economic health.

Having experienced psychosis herself, a psychologist wants us to rethink how we understand and treat this complex condition.

Veterans with chronic pain should consider reducing alcohol usage to combat symptoms.

Studies around the world are measuring the effects of the pandemic on children and adolescents.

With partisan political warfare, civil unrest, and the presidential race, how can mental health professionals assess and address “election anxiety”?

Abnormal glutamate and GABA levels may underlie cognitive deficits. A recent study investigated these associations in a large group of antipsychotic-naïve patients with first-episode psychosis.

Dak Prescott of the Dallas Cowboys spoke up about his mental illness and was questioned. Dr Calhoun argues his bravery should be commended, not criticized.

In many clinical situations to "do no harm" requires us to know what we know, know what we don’t know, and consult with a colleague who likely knows more than we do.

The chairman of Psychiatric Times' parent company, MJH Life Sciences, introduces the October issue.

Financial distress in patients with ADHD greatly increases risk of suicide. Read more.

The pandemic has brought into focus treatment barriers, disruption in care, and possibly negative outcomes in the mental health of university students. To better understand the specific challenges of out-of-state students, the authors conducted an anonymous national survey of college psychiatrists.

Schizophrenia is associated with an increased prevalence of alcohol use disorders. A post-hoc analysis of the clinical course of the 2 disorders is an important change in this understudied and often overlooked population.

Politics have gotten in the way of mask-wearing, and they should not.

A Psychiatrist Looks Back on His Career and Considers the Role of the Placebo Effect in Treatment.

The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.

Mental health providers who battle a pandemic may find that it unsettles their deepest sense of self.

Dr Cheng shares his experience with racism in the hopes that we can join together to create a better country for everyone.

Institutionalized racism is built into the very foundations of medical specialty organizations. The American Academy of Pediatrics recently issued an apology for said racism. Here is why other institutions should follow suit...